n recent years mesenchymal stromal cells (MSC) have emerged as a major new form of cell therapy. While the original perception was that MSC were stem/progenitor cells with the potential to contribute to the regeneration of tissue, more recent data suggest that the principal mechanism of MSC activity is through the release of soluble mediators that elicit the observed biologic response. Future studies are needed to identify more completely the spectrum of therapeutic applications and delineate better the associated molecular and cellular mechanisms.
How do mesenchymal stromal cells exert their therapeutic benefit? / E. M., Horwitz; Dominici, Massimo. - In: CYTOTHERAPY. - ISSN 1465-3249. - STAMPA. - 10:8(2008), pp. 771-774. [10.1080/14653240802618085]
How do mesenchymal stromal cells exert their therapeutic benefit?
DOMINICI, Massimo
2008
Abstract
n recent years mesenchymal stromal cells (MSC) have emerged as a major new form of cell therapy. While the original perception was that MSC were stem/progenitor cells with the potential to contribute to the regeneration of tissue, more recent data suggest that the principal mechanism of MSC activity is through the release of soluble mediators that elicit the observed biologic response. Future studies are needed to identify more completely the spectrum of therapeutic applications and delineate better the associated molecular and cellular mechanisms.File | Dimensione | Formato | |
---|---|---|---|
Horwitz & Dominici Cytotherapy 2008.pdf
Solo gestori archivio
Tipologia:
Versione pubblicata dall'editore
Dimensione
129.62 kB
Formato
Adobe PDF
|
129.62 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris